Shandong Weigao Blood Purification Products Co (SHSE:603014) Total Operating Expense: ¥947 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603014 Shandong Weigao Blood Purification Products Co Ltd SHSE:603014
36 GF Score
Price ¥31.85
! 3 Warning Signs
View Full Analysis

What is Shandong Weigao Blood Purification Products Co Total Operating Expense?

Shandong Weigao Blood Purification Products Co SHSE:603014 -1.64% 36 Total Operating Expense is ¥947 Mil as of Mar. 2026. GuruFocus rates SHSE:603014 with a GF Score™ of 36/100. The stock has 3 warning signs investors should review.

Shandong Weigao Blood Purification Products Co's Total Operating Expense for the three months ended in Mar. 2026 was ¥209 Mil. Shandong Weigao Blood Purification Products Co's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ¥947 Mil.

Shandong Weigao Blood Purification Products Co Total Operating Expense Related Terms

Shandong Weigao Blood Purification Products Co Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Shandong Weigao Blood Purification Products Co's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Weigao Blood Purification Products Co Total Operating Expense Chart

Shandong Weigao Blood Purification Products Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial 1,001.42 1,082.74 0.00 967.36 959.02

Shandong Weigao Blood Purification Products Co Quarterly Data
Dec20 Dec21 Dec22 Jun23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 221.74 248.22 235.61 253.44 209.32
SHSE:603014
36GF Score
Shandong Weigao Blood Purification Products Co Ltd SHSE:603014
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shandong Weigao Blood Purification Products Co Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥947 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of ¥947 Mil mean?
Shandong Weigao Blood Purification Products Co (SHSE:603014) has a Total Operating Expense of ¥947 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Shandong Weigao Blood Purification Products Co and its competitors.
Is Shandong Weigao Blood Purification Products Co's Total Operating Expense too high?
Shandong Weigao Blood Purification Products Co's current Total Operating Expense is ¥947 Mil. Overall, Shandong Weigao Blood Purification Products Co has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Shandong Weigao Blood Purification Products Co's Total Operating Expense compare to ABT and SYK?
Shandong Weigao Blood Purification Products Co's Total Operating Expense of ¥947 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Shandong Weigao Blood Purification Products Co and its competitors. Shandong Weigao Blood Purification Products Co's current Total Operating Expense is ¥947 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Weigao Blood Purification Products Co stock overvalued right now?
Shandong Weigao Blood Purification Products Co (SHSE:603014) has a current Total Operating Expense of ¥947 Mil. The current Total Operating Expense is ¥947 Mil. Shandong Weigao Blood Purification Products Co's overall GF Score™ is 36/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Shandong Weigao Blood Purification Products Co (SHSE:603014), the current Total Operating Expense is ¥947 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Shandong Weigao Blood Purification Products Co Business Description

Address No. 7, Weigao West Road, Torch High-tech Industrial Development Zone, Shandong Province, Weihai, CHN, 264200
Shandong Weigao Blood Purification Products Co Ltd engaged in research and development, production and sales of blood purification medical products.
36GF Score

Get the complete analysis for SHSE:603014

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥31.85
Price